Download PDF
Thromb Haemost 1987; 57(01): 124
DOI: 10.1055/s-0038-1651077
Letters to the Editor
Schattauer GmbH Stuttgart

The Incidence of Thrombotic Manifestations in AT III Abnormalities -Rejoinder

A M Fischer
Laboratoire d’Hématologie, Faculté Necker-Enfants Malades, 156 rue de Vaugirard, 75015 Paris, France
› Author Affiliations
Further Information

Publication History

Received 08 August 1986

Accepted after revision 01 October 1986

Publication Date:
06 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Béguin S, Desnos M. Antithrombin III Alger: a new homozygous AT III variant. Thromb Haemostas 1986; 55: 218-222
    PubMedGoogle Scholar
  • 2 Wolf M, Boyer C, Lavergne JM, Larrieu MJ. A new familial variant of Antithrombin III: Antithrombin III Paris. Br J Haematol 1982; 51: 285-295
    CrossrefPubMedGoogle Scholar
  • 3 Nagy I, Losonczy H. Three types of hereditary AT III deficiency. Thromb Haemostas 1979; 42: 187 (Abstr)
    PubMedGoogle Scholar
  • 4 Howarth DJ, Samson D, Stirling Y, Seghatchian MJ. Antithrombin III “Northwick Park”: a variant antithrombin with normal affinity for heparin but reduced heparin co-factor activity. Thromb Haemostas 1985; 53: 314-319
    PubMedGoogle Scholar
  • 5 Marcum JA, Rosenberg RD. Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 1984; 23: 1730-1737
    CrossrefPubMedGoogle Scholar
  • 6 Fischer AM, Sternberg C, Dautzenberg MD, Meriane F, Beguin S, Cornu P. Comparative effect of heparin and heparan sulfate on a new abnormal antithrombin III. Thromb Haemostas 1985; 54: 49 (Abstr)
    PubMedGoogle Scholar